Tag: GSK Acquisition

spot_imgspot_img

GSK Launches Tender Offer to Acquire Precision Oncology Innovator Nuvalent, Inc.at $124.00

GSK plc has officially commenced a tender offer to acquire all issued and outstanding shares of Class A and Class B common stock of Nuvalent,...